RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Core Fucosylation Represses SMURF1-Dependent Degradation of CD47 to Promote Tumor Immune Evasion.
Core Fucosylation Represses SMURF1-Dependent Degradation of CD47 to Promote Tumor Immune Evasion.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
糖基化,即聚糖与蛋白质、脂质和RNA的共价连接,在调控多种生物过程中具有基础性作用。肿瘤微环境中的糖基化模式发生异常改变,并与肿瘤免疫逃逸密切相关。
然而,糖基化调控肿瘤免疫逃逸的分子机制尚不清楚。我们发现,分化簇47(CD47),一种固有免疫检查点蛋白,高度修饰有核心岩藻糖基化的N-连接聚糖。由岩藻糖基转移酶8(FUT8)介导的CD47在天冬酰胺111(N111)位点的核心岩藻糖基化可减少CD47的泛素化和降解。阻断N111糖基化可抑制CD47表达并促进巨噬细胞对肿瘤细胞的吞噬作用。
此外,消除N111糖基化可促进CD103+树突状细胞(DCs)的浸润,从而导致自然杀伤(NK)细胞募集增加,并在小鼠肝细胞癌(HCC)模型中抑制肿瘤生长。核心岩藻糖基化抑制剂与抗CD47抗体联合治疗在HCC模型中协同促进治疗效果。
最后,人HCC标本中FUT8水平与CD47表达呈正相关,与CD103+ DC和NK细胞的浸润呈负相关。总之,本研究揭示了肿瘤细胞中CD47上调的机制,并强调了靶向FUT8-SMURF1-CD47轴作为改善抗肿瘤免疫应答的治疗策略的潜力。
Glycosylation, the covalent attachment of glycans to proteins, lipids, and RNAs, is fundamental in regulating diverse biological processes. Glycosylation patterns are aberrantly altered in the tumor microenvironment and closely associated with tumor immune escape.
However, the molecular mechanisms by which glycosylation regulates tumor immune escape are poorly understood.
We show that Cluster of Differentiation 47 (CD47), an innate immune checkpoint protein, is highly modified with core fucosylated N-linked glycans. Core fucosylation of CD47 mediated by fucosyltransferase 8 (FUT8) at asparagine 111 (N111) reduces CD47 ubiquitination and degradation. Blockade of N111 glycosylation represses CD47 expression and promotes macrophage phagocytosis of tumor cells.
Furthermore, elimination of N111 glycosylation promotes the infiltration of CD103 + dendritic cells (DCs), leading to the increased recruitment of natural killer (NK) cells and inhibition of tumor growth in a murine hepatocellular carcinoma (HCC) model. Combined treatment with core fucosylation inhibitors and an anti-CD47 antibody synergistically promotes therapeutic efficacy in the HCC model.
Finally, FUT8 levels in human HCC specimens are positively correlated with CD47 expressions and negatively correlated with the infiltration of CD103 + DC and NK cells. Collectively, this study reveals a mechanism underlying CD47 upregulation in tumor cells and highlights the potential of targeting the FUT8-SMURF1-CD47 axis as a therapeutic strategy to improve anti-tumor immune responses.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。